US regulator FDA clears Johnson & Johnson's single-dose COVID vaccine for emergency use

U.S. regulators on Saturday authorized a third COVID-19 vaccine, a single-dose shot by Johnson & Johnson that could help speed vaccinations. The move by the Food and Drug Administration came after an expert panel debated the evidence to allow widespread use of J&J’s vaccine. J&J has said it can supply enough to vaccinate 20 million people by the end of March.


READ  Here's how Sheryl Sandberg plunged from global icon to just another powerful tech executive


Please enter your comment!
Please enter your name here